Immunovia AB (publ) (STO:IMMNOV)

Immunovia AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	34.9	77.46	25.32	76.79	106.04	287.41
Cash & Short-Term Investments	34.9	77.46	25.32	76.79	106.04	287.41
Cash Growth	19.23%	205.94%	-67.03%	-27.59%	-63.10%	-38.65%
Accounts Receivable	0.32	0.04	-	0.15	0.25	0.07
Other Receivables	2.55	1.27	2.15	1.3	3.4	4.41
Receivables	2.87	1.31	2.15	1.45	3.65	4.48
Inventory	0.55	0.12	-	-	2.02	2.15
Prepaid Expenses	-	1.52	1.12	2.28	3.91	3.06
Total Current Assets	38.32	80.41	28.59	80.51	115.62	297.1
Property, Plant & Equipment	3.29	0.97	1.95	15.12	47.88	46.53
Other Intangible Assets	6.29	6.72	1.94	2.55	23.52	24.66
Long-Term Deferred Charges	-	-	-	-	110.07	122.49
Other Long-Term Assets	0.13	0.13	0.55	0.51	3.5	3.03
Total Assets	48.04	88.21	33.04	98.68	300.59	493.81

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	5.64	0.88	2.5	1.58	3.07
Accrued Expenses	-	2.66	7.84	15.01	15.17	20.21
Current Portion of Leases	3.27	0.86	0.68	8.48	4.87	6.11
Other Current Liabilities	21.13	6.53	6.3	3.92	2.46	3.37
Total Current Liabilities	24.4	15.69	15.69	29.9	24.09	32.75
Long-Term Leases	-	-	-	1.79	32.7	27.16
Other Long-Term Liabilities	-	7.78	5.71	-	-	0
Total Liabilities	24.4	23.48	21.39	31.69	56.79	59.91

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	20.18	20.18	5.09	2.26	1.13	1.13
Additional Paid-In Capital	1,309	1,309	1,186	1,136	1,016	1,016
Retained Earnings	-1,322	-1,281	-1,135	-1,059	-749.39	-581.3
Comprehensive Income & Other	16.56	16.56	-44.13	-12.92	-24.31	-1.66
Shareholders' Equity	23.64	64.74	11.65	66.99	243.8	433.9
Total Liabilities & Equity	48.04	88.21	33.04	98.68	300.59	493.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.27	0.86	0.68	10.27	37.57	33.26
Net Cash (Debt)	31.63	76.6	24.64	66.52	68.47	254.14
Net Cash Growth	9.81%	210.91%	-62.96%	-2.84%	-73.06%	-41.62%
Net Cash Per Share	0.06	0.22	0.30	1.71	3.03	11.23
Filing Date Shares Outstanding	672.67	672.67	261.91	45.29	22.63	22.63
Total Common Shares Outstanding	672.67	672.67	169.71	45.29	22.63	22.63
Working Capital	13.92	64.71	12.91	50.61	91.53	264.35
Book Value Per Share	0.04	0.10	0.07	1.48	10.77	19.17
Tangible Book Value	17.34	58.02	9.71	64.44	220.28	409.25
Tangible Book Value Per Share	0.03	0.09	0.06	1.42	9.73	18.08
Machinery	-	0.88	2.88	2.65	23.17	20.92
Leasehold Improvements	-	-	1.29	9.22	9.27	9.11

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error